Search

Search Constraints

You searched for: Author/Creator de Meij, T

Search Results

1. DOP67 First-line infliximab is cost-effective compared to conventional treatment in paediatric Crohn's Disease – Results from the TISKids study. (21st January 2022)

2. OP32 Stool microbiome communities predict remission in treatment-naïve Pediatric Crohn's Disease patients. (27th May 2021)

3. P214 Long-term outcomes of paediatric patients admitted for Acute Severe Colitis - a multicentre study from the paediatric IBD porto group of ESPGHAN. (16th January 2018)

4. P448 Long term effectiveness of first-line infliximab treatment compared to conventional treatment in paediatric moderate-to-severe Crohn's disease – an update from the TISKids study. (30th January 2023)

5. P458 Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn's disease (the SPEED-UP study) - A multi-center study from the paediatric IBD Porto group of ESPGHAN. (21st January 2022)

7. P711 Stool microbiome communities predict remission in pediatric Crohn's disease patients even after start of treatment. (21st January 2022)

8. P819 Whole-exome sequencing in early-onset primary sclerosing cholangitis: first results of the WHELP study. (25th January 2019)